|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
|
|---|---|---|
| Revenues, net | ||
| Cost of revenues | ||
| Gross profit | ||
| Operating expenses | ||
| Selling and marketing expenses | ||
| General and administrative expenses | ||
| Research and development expenses | ||
| Allowance for expected credit losses | ||
| Total operating expenses | ||
| Operating (loss) income | ||
| Other income (expense): | ||
| Other expense | ||
| Other income (expense) | ||
| Interest income | ||
| Interest expense | ||
| Total other income (expenses) | ||
| (Loss) income before income tax | ||
| Income tax expenses (benefits) | ||
| Net (loss) income | ||
| Other comprehensive income (loss): | ||
| Foreign currency translation adjustments | ||
| Total comprehensive (loss) income | ||
| (Loss) earnings per share: | ||
| Ordinary shares – basic (in Dollars per share) | ||
| Ordinary shares – diluted (in Dollars per share) | ||
| Weighted average shares outstanding used in calculating basic and diluted earnings per share: | ||
| Ordinary shares – basic (in Shares) | ||
| Ordinary shares – diluted (in Shares) |
Loading...
